Is Retinyl palmitate safe for babies and kids?
Moderate risk for kidsInfants are more vulnerable to Retinyl palmitate than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
What is retinyl palmitate?
The IUPAC name is [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate.
Also known as: [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate, VITAMIN A PALMITATE, Retinol palmitate, Retinol, hexadecanoate.
- IUPAC name
- [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
- CAS number
- 79-81-2
- Molecular formula
- C36H60O2
- Molecular weight
- 524.9 g/mol
- SMILES
- CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C
- PubChem CID
- 5280531
Risk for babies
Moderate riskInfants are more vulnerable to Retinyl palmitate than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.
Risk for pregnant and nursing people
Moderate riskRetinoids as a class are established human teratogens: isotretinoin (Accutane), tretinoin, and high-dose oral vitamin A all cause characteristic fetal malformations (craniofacial, cardiac, CNS, thymic defects) during organogenesis. The question for retinyl palmitate in cosmetics is whether topical application results in fetal retinoid exposure at teratogenic levels. Dermal absorption of retinyl palmitate from cosmetics is generally low; studies measuring plasma retinol and retinyl ester levels following topical retinoid application find minimal systemic absorption from retinyl palmitate formulations at typical use concentrations (unlike prescription retinoic acid preparations, which do produce measurable systemic absorption). Most dermatology and teratology authorities consider topical retinyl palmitate in cosmetics safe during pregnancy at intended use concentrations, contrasting sharply with oral high-dose vitamin A supplementation or prescription topical tretinoin, which carry real teratogenic risk. Nevertheless, the teratogenic potential of the retinoid class and uncertainty about absorption from high-concentration products or frequent application to large body areas has led most pregnancy safety guidelines to recommend avoidance of retinoid-containing skin care products (including retinyl palmitate) during pregnancy as a precautionary measure. The risk is considered low but not negligible given the class mechanism, and alternative non-retinoid skin care is readily available.
Regulatory consensus
3 regulatory and scientific bodies have classified Retinyl palmitate. The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| EPA CTX / Genetox | — | Genotoxicity: positive (Ames: positive, 13 positive / 4 negative reports) | |
| EPA CTX / Genetox | — | Genotoxicity: positive (Ames: positive, 13 positive / 4 negative reports) | |
| EPA CTX / Skin-Eye | — | skin sensitisation: in vivo (non-LLNA): Not likely to be sensitizing (score: low) |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter retinyl palmitate
- Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
- Occupational Environments — Factories, Warehouses, Transportation vehicles
- Consumer Products — dietary supplements, fortified foods, energy drinks
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Retinyl palmitate:
-
Tocopherol (Vitamin E) based antioxidants
Trade-offs: Lower thermal stability than synthetic BHT/BHA for some polymer applications.Relative cost: 2-5× conventional
Frequently asked questions
Is retinyl palmitate safe for kids?
Infants are more vulnerable to Retinyl palmitate than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
What products contain retinyl palmitate?
Retinyl palmitate appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments); dietary supplements (Consumer products).
What should I do if my child is exposed to retinyl palmitate?
Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.
Why do regulators disagree about retinyl palmitate?
Retinyl palmitate has been classified by 3 agencies including EPA CTX / Genetox, EPA CTX / Genetox, EPA CTX / Skin-Eye, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.
See Retinyl palmitate in the baby app
Look up products containing retinyl palmitate, compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (2)
- US FDA: Sunscreen Drug Products for Over-the-Counter Human Use — Proposed Rule, GRASE Determinations, and Retinyl Palmitate Safety Data Call-In (2019) (2019) — regulatory
- NTP Technical Report: Photocarcinogenesis Study of Retinoic Acid and Retinyl Palmitate in SKH-1 Mice — Study No. 568 (NTP TR 568) (2012) — regulatory
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →